Identification of Db- and Kb-restricted subdominant cytotoxic T-cell responses in lymphocytic choriomeningitis virus-infected mice - PubMed (original) (raw)

. 1998 Jan 5;240(1):158-67.

doi: 10.1006/viro.1997.8934.

Affiliations

• PMID: 9448700
• DOI: 10.1006/viro.1997.8934

Free article

Identification of Db- and Kb-restricted subdominant cytotoxic T-cell responses in lymphocytic choriomeningitis virus-infected mice

R G van der Most et al. Virology. 1998.

Free article

Abstract

Antiviral cytotoxic T-cells are critical for control of lymphocytic choriomeningitis virus (LCMV) infection in mice. In H-2b mice, the antiviral response is directed against three Db-restricted epitopes in the viral nucleoprotein (NP396-404) and glycoprotein (GP276-286 and GP33-41). Our present data revealed a clear hierarchy among these three epitopes, in which NP396-404 is immunodominant, followed by GP33-41 and GP276-286, respectively. In order to identify additional CTL epitopes in the LCMV nucleoprotein and glycoprotein, we used the motifs for Db2- and Kb-binding peptides, combined with MHC class I-binding assays. Out of 23 Db motif-fitting peptides, we identified 4 Db binders, one of which (GP92-101) turned out to be a new CTL epitope. Among 28 Kb motif-fitting peptides, 12 bound Kb, and one of these (NP205-212) was a CTL epitope. Both newly identified CTL peptides were recognized by LCMV-immune splenocytes after secondary in vitro stimulation. Both peptides bound their MHC class I molecules with intermediate affinity (470 and 170 nM for GP92-101 and NP205-212, respectively). Responses against these peptides were weaker than the responses against the three major epitopes. None of the high affinity binders were new epitopes, suggesting that high affinity binders are either immunodominant epitopes or no epitopes at all. Thus, analysis of 51 Kb and Db motif-fitting peptides yielded 2 new, subdominant epitopes. Immunization of C57BL/6 mice with these peptides, or vaccinia virus recombinants expressing these epitopes as minigenes, protected against chronic LCMV infection, demonstrating that immunization with subdominant epitopes can confer protection against chronic viral infection.

PubMed Disclaimer

Similar articles

• Analysis of cytotoxic T cell responses to dominant and subdominant epitopes during acute and chronic lymphocytic choriomeningitis virus infection.
  van der Most RG, Sette A, Oseroff C, Alexander J, Murali-Krishna K, Lau LL, Southwood S, Sidney J, Chesnut RW, Matloubian M, Ahmed R. van der Most RG, et al. J Immunol. 1996 Dec 15;157(12):5543-54. J Immunol. 1996. PMID: 8955205
• A protective cytotoxic T cell response to a subdominant epitope is influenced by the stability of the MHC class I/peptide complex and the overall spectrum of viral peptides generated within infected cells.
  Gallimore A, Hombach J, Dumrese T, Rammensee HG, Zinkernagel RM, Hengartner H. Gallimore A, et al. Eur J Immunol. 1998 Oct;28(10):3301-11. doi: 10.1002/(SICI)1521-4141(199810)28:10<3301::AID-IMMU3301>3.0.CO;2-Q. Eur J Immunol. 1998. PMID: 9808199
• Hierarchies of antigen-specific cytotoxic T-cell responses.
  Gallimore A, Hengartner H, Zinkernagel R. Gallimore A, et al. Immunol Rev. 1998 Aug;164:29-36. doi: 10.1111/j.1600-065x.1998.tb01205.x. Immunol Rev. 1998. PMID: 9795761 Review.
• Prospects for T cell immunotherapy of tumours by vaccination with immunodominant and subdominant peptides.
  Melief CJ, Kast WM. Melief CJ, et al. Ciba Found Symp. 1994;187:97-104; discussion 104-12. doi: 10.1002/9780470514672.ch7. Ciba Found Symp. 1994. PMID: 7796678 Review.

Cited by

• Targeting of non-dominant antigens as a vaccine strategy to broaden T-cell responses during chronic viral infection.
  Holst PJ, Jensen BA, Ragonnaud E, Thomsen AR, Christensen JP. Holst PJ, et al. PLoS One. 2015 Feb 13;10(2):e0117242. doi: 10.1371/journal.pone.0117242. eCollection 2015. PLoS One. 2015. PMID: 25679375 Free PMC article.
• Molecular and functional dissection of the H-2Db-restricted subdominant cytotoxic T-cell response to lymphocytic choriomeningitis virus.
  Hudrisier D, Riond J, Gairin JE. Hudrisier D, et al. J Virol. 2001 Mar;75(5):2468-71. doi: 10.1128/JVI.75.5.2468-2471.2001. J Virol. 2001. PMID: 11160751 Free PMC article.
• Revisiting estimates of CTL killing rates in vivo.
  Yates A, Graw F, Barber DL, Ahmed R, Regoes RR, Antia R. Yates A, et al. PLoS One. 2007 Dec 12;2(12):e1301. doi: 10.1371/journal.pone.0001301. PLoS One. 2007. PMID: 18074025 Free PMC article.
• In vivo selection of a lymphocytic choriomeningitis virus variant that affects recognition of the GP33-43 epitope by H-2Db but not H-2Kb.
  Puglielli MT, Zajac AJ, van der Most RG, Dzuris JL, Sette A, Altman JD, Ahmed R. Puglielli MT, et al. J Virol. 2001 Jun;75(11):5099-107. doi: 10.1128/JVI.75.11.5099-5107.2001. J Virol. 2001. PMID: 11333891 Free PMC article.
• Viral infection reveals hidden sharing of TCR CDR3 sequences between individuals.
  Mark M, Reich-Zeliger S, Greenstein E, Biram A, Chain B, Friedman N, Madi A. Mark M, et al. Front Immunol. 2023 May 30;14:1199064. doi: 10.3389/fimmu.2023.1199064. eCollection 2023. Front Immunol. 2023. PMID: 37325645 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations Database

• Molecular Biology Databases

  • Immune Epitope Database and Analysis Resource

• Research Materials

  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • NCI CPTAC Assay Portal